the results of a clinical trial comparing slow-release 5-aminosalicylic acid tablets ( pentasa ) and enteric-coated sulfasalazine tablets ( salazopyrin ) with regard to the efficacy of maintaining ulcerative colitis patients in remission for 12 mo and with regard to safety of treatment are reported .
C0036078
sulfasalazine
C0699547
salazopyrin